The Branching Point in Erythro-Myeloid

Differentiation by Perie, Leila et al.
Article
The Branching Point in Erythro-Myeloid
DifferentiationGraphical AbstractHighlightsd Classically defined commonmyeloid progenitors (CMPs) are
highly heterogeneous
d Most individual CMPs yield either erythrocytes or myeloid
cells
d A true common progenitor exists within the multipotent
progenitor (MPPs) pool
d The divergence between myeloid cells and erythrocytes
starts within the MPPsPerie´ et al., 2015, Cell 163, 1655–1662
December 17, 2015 ª2015 Elsevier Inc.
http://dx.doi.org/10.1016/j.cell.2015.11.059Authors
Leı¨la Perie´, Ken R. Duffy, Lianne Kok,
Rob J. de Boer, Ton N. Schumacher
Correspondence
leila.perie@curie.fr (L.P.),
t.schumacher@nki.nl (T.N.S.)
In Brief
The so-called common myeloid
progenitors (CMPs) are highly
heterogeneous, with most individual
CMPs yielding either only erythrocytes or
only myeloid cells after transplantation.
This provides in vivo evidence for amodel
of early parallel lineage branching within
the multipotent progenitor pool that is in
sharp contrast with the standardmodel of
hematopoiesis.
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Development of mature blood cell progenies from
hematopoietic stem cells involves the transition
through lineage-restricted progenitors. The first
branching point along this developmental process
is thought to separate the erythro-myeloid and
lymphoid lineage fate by yielding two intermediate
progenitors, the common myeloid and the com-
mon lymphoid progenitors (CMPs and CLPs). Here,
we use single-cell lineage tracing to demonstrate
that so-called CMPs are highly heterogeneous
with respect to cellular output, with most individ-
ual CMPs yielding either only erythrocytes or only
myeloid cells after transplantation. Furthermore,
based on the labeling of earlier progenitors, we
show that the divergence between the myeloid and
erythroid lineage develops within multipotent pro-
genitors (MPP). These data provide evidence for a
model of hematopoietic branching in which multiple
distinct lineage commitments occur in parallel within
the MPP pool.
INTRODUCTION
During hematopoiesis, hematopoietic stem cells (HSCs) self-
renew or differentiate into all blood cell types through successive
stages of lineage commitment, a process that has become a
prototype of multi-lineage diversification from a stem cell pool.
The prevailing model of hematopoiesis predicts a step-by-step
process of lineage commitment in which HSCs give rise to multi-
potent progenitors (MPPs) that subsequently generate interme-
diate lineage restricted progenitors. The strongest support for
this model has come from the identification of the common
lymphoid progenitor (CLP) (Kondo et al., 1997) that produces
lymphoid cells (i.e., T and B lymphocytes and NK cells) and the
common myeloid progenitor (CMP) (Akashi et al., 2000) that
gives rise to granulocyte-macrophage (GM) progenitors and to
the megakaryocyte-erythroid (MkE) progenitors. In this model,
the lymphoid-myeloid split forms the first step in lineage commit-
ment downstream of MPPs (Reya et al., 2001). However, a num-Cber of studies have questioned the CMP-CLP split as the first
step of commitment. Reports of unequal output of GM or MkE
progenitors by subsets of CMPs (Iwasaki et al., 2005; Nutt
et al., 2005; Terszowski et al., 2005) suggest a separation be-
tween the erythroid and myeloid lineages earlier than the CMP
stage. Additionally, earlier bypasses toward lymphoid, myeloid
(GM), or MkE commitment have been reported in HSCs (Benz
et al., 2012; Dykstra et al., 2007; Sanjuan-Pla et al., 2013; Yama-
moto et al., 2013) and MPPs (Adolfsson et al., 2005; Cabezas-
Wallscheid et al., 2014; Igarashi et al., 2002; Lai and Kondo,
2006; Ma˚nsson et al., 2007; Miyawaki et al., 2015; Naik et al.,
2013; Pietras et al., 2015; Takano et al., 2004; Yoshida et al.,
2006). Based on some of these data, a myelo-lymphoid versus
erythro-megakaryocytic separation has been proposed as the
first commitment step (Adolfsson et al., 2005), but other results
have also contradicted this model (Boyer et al., 2011; Forsberg
et al., 2006). Overall, which lineage commitment occurs first be-
tween the lymphoid, myeloid, or erythroid lineages remains to be
determined. Importantly, most of the results that bear on this
question have been obtained using in vitro clonal assays or pop-
ulation-based tracking approaches that can miss in vivo cellular
heterogeneity and, thereby, influence our interpretation of line-
age commitment. To address this issue, here we have utilized
cellular barcoding technology that allows the in vivo tracking of
single cell fate (Gerlach et al., 2013; Gerrits et al., 2010; Lu
et al., 2011; Naik et al., 2013, 2014; Schepers et al., 2008) to
describe the steps of myeloid and erythroid commitment during
successive stages of hematopoietic development.
RESULTS
To understand the clonal output of individual CMPs, we obtained
mouse CMPs based on their original description (ckit+S-
ca1CD16/32lowCD34+) (Akashi et al., 2000), labeled these
with unique genetic barcodes in a 6 hr in vitro process, and as-
sessed their ability for myelopoiesis (for the GM lineage) and
erythropoiesis (for the MkE lineage). At different time points after
transplantation of 23 103 barcode-labeled CMPs into irradiated
recipients, CMP-derived myeloid cells (GFP+CD11b+) and eryth-
roblasts (GFP+Ter119+) were sorted and assessed for their bar-
code identity using PCR and deep-sequencing (Figures 1A, 1C,
and 1D; Table S1). Erythroblasts were measured as a proxy for
erythropoiesis, as they retain the nucleus required for barcodeell 163, 1655–1662, December 17, 2015 ª2015 Elsevier Inc. 1655
Figure 1. Summary of Experimental Setup and Sort Profiles of Progenitors and Output Cell Types, Related to Table S1
(A) Progenitors (HSC, MPP, or CMP) were transduced with low efficiency (5%–15%) to minimize the chance of two different barcode virus particles integrating
into the same progenitor. Progenitors from a single transduction batch were then transplanted into 2–8 5gy irradiated mice (to allow later comparison of barcodes
between mice as a control for random barcode sharing). At the indicated time points after transplantation, myeloid cells (CD11b+), erythroblasts (Ter119+), DCs
(CD11c+) and B cells (CD19+) were isolated from the spleen of recipient mice. Each sample was split into two replicates. Barcodes were amplified by PCR and
analyzed by deep sequencing.
(legend continued on next page)
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Figure 2. Individual CMPs Yield Either Eryth-
rocytes or Myeloid Cells, Related to Figures
S1, S2, and S3
(A–G) Barcode-labeled CMPs were transplanted
into 5gy-irradiated mice. At day 6 (A and B) or day 14
(C–E) post-transplantation, myeloid cells (CD11b+),
erythroblasts (Ter119+), and DCs (CD11c+) were
recovered from spleen and barcode content was
analyzed. (A and C) Proportion of CMPs classified as
producing either M (myeloid cells), E (erythroblasts),
or both, using a 1% classification threshold (other
thresholds in Figure S1). (B and D) Quantitative
contribution of the three classes to each lineage
(mean + SD). (E) Heatmap representation of the
output of individual CMPs (rows) to different cell
types (columns) at day 14 (248 barcodes, pooled
data of four mice), and arcsine transformed data
clustered by complete linkage using Euclidean dis-
tances. For day 6, 636 single CMPs were analyzed
(58 ± 46 CMPs/mouse), data shown in (A) and (B)
displays average + SD over three experiments, four
mice per experiment; for day 14, 248 single CMPs
were analyzed (62 ± 18 CMPs/mouse), data shown
in (C) and (D) displays average + SD over two ex-
periments, two mice per experiment. Quality con-
trols in Figure S1. (G) Proportion of CMPs classified
as producing output as defined in (A) in bonemarrow
at day 14 post-transplantation.
(H) Quantitative contribution of the three classes
to each lineage (mean + SD). For (F) and (G), 89
barcodes were analyzed (29 ± 6 CMPs/mouse)
over two experiments, two mice per experiment),
other thresholds than 1% displayed in Figures S2A
and S2B.analysis. Subsequently, barcode-labeled CMPs were assigned
to a class of (lineage-biased) progenitor using a hand-tailored
classifier that is based on cellular output of each individual pro-
genitor toward the examined lineages (Naik et al., 2013). Six days
after transplantation, we found that 95% of the engrafted CMPs
showed highly biased (>99% of cellular output) production of
myeloid cells (69% ± 17% of presumed CMPs) or highly biased(B) Bonemarrow progenitors were enriched using anti-CD117 (c-kit) magnetic beads and subsequently stain
CD135 (Flt3), CD34, and CD150. MPP and HSC were sorted using the gates shown.
(C) Gating strategy used to isolate CMP.
(D) Splenic cells were separated into a Ter119+ and Ter119 fraction by magnetic-bead-based selection. Th
cells, and DCs as shown. The Ter119+ fraction was used to sort erythroblasts as shown.
Cell 163, 1655–1662, D(>99% of cellular output) production of
erythroblasts (26% ± 13% of presumed
CMPs) (Figure 2A; quality controls shown
in Figures S1A and S1B; effect of classifi-
cation threshold in Figures S1D and S1F).
Furthermore, this large pool of myeloid-
biased or erythroid-biased CMPs ac-
counted for 82% ± 13% and 53% ± 27%
of total myeloid cell and erythroblast pro-
duction, respectively (Figures 2B and
S1D). Only 5% ± 4% of CMPs produced
appreciable numbers of both myeloid cells
and erythroblasts, overall accounting for11% ± 12% of total myeloid cell reads and 40% ± 27% of total
erythroblast reads (Figures 2B, S1D, and S1F). The observation
of this high frequency of uni-outcome CMPs could not be ex-
plained by limits of detection or sampling issues, as determined
by the following detection controls: (1) the per progenitor output
(as measured in read counts) of uni-outcome CMPs toward one
specific lineage (i.e., myeloid cells or erythroblasts) was as highed with antibodies against CD16/32, CD117, Sca-1,
e Ter119 fraction was used to sort B cells, myeloid
ecember 17, 2015 ª2015 Elsevier Inc. 1657
as the per progenitor output of bi-outcome CMPs toward the
same lineage (Figure S1H), and (2) the absence of output of
uni-outcome CMPs toward the other lineage was reproducible
in technical replicates before applying the replicate filter (data
not shown). In other words, lack of detectable output of a given
CMP toward either the myeloid cell or erythroblast compartment
was a reproducible feature.
Similarly, when assessed 14 days after transplantation, 74%
of the engrafted CMP produced essentially only myeloid cells
(35% ± 3% of presumed CMPs) or only erythroblasts (39% ±
12% of presumed CMPs) (Figures 2C and S1E), accounting
for 74% ± 16% and 53% ± 35% of total myeloid cell and
erythroblast production, respectively (Figure 2D; effect of the
thresholds shown in Figure S1G; detection control shown in Fig-
ure S1I). Also at this point in time, only a minority of CMPs
showed substantial production of both myeloid cells and eryth-
roblasts. Finally, heterogeneity in output toward either the
myeloid and erythrocyte lineage is not specific to the spleen
but was also observed in the bone marrow, where 90% of the
engrafted CMP also produced essentially only myeloid cells
(35% ± 9% of presumed CMPs) or essentially only erythroblasts
(55% ± 12% of presumed CMPs) (Figures 2F, 2G, S2A, and
S2B). The observation of the somewhat higher fraction of
CMPs with detectable output in both the myeloid and erythro-
cyte lineage over time (day 6: 5% ± 4% of presumed CMPs;
day 14: 26% ± 15% of presumed CMPs) may either be inter-
preted as a more prolonged engraftment potential of the small
subset of CMPs producing both erythroblasts and myeloid cells
or as contamination of CMPs by LinSca1+ckit+ (LSK) cells (Fig-
ure S1C), whose contribution may also be expected to increase
over time after transplantation. A preponderance of uni-output
was also observed at two CMP doses tested (Figures S2C
and S2D).
In addition to heterogeneity in output toward the myeloid
and erythrocyte lineage, further disparity in cellular output be-
tween individual CMPs was observed at day 14 after trans-
plantation (Figures 2E and S3A), with 16% ± 4% of CMPs
producing detectable output only in the dendritic cell (DC) line-
age (Figure S3B, note that DC production could not be as-
sessed at day 6). These DC uni-outcome CMPs accounted
for 24% ± 25% of total DC production (Figure S3B), and their
presence could not be explained by limits of detection (Fig-
ure S3C). While these data do not exclude the possibility that
some DC uni-outcome CMPs might have produced myeloid
cells or erythroblasts at an earlier point in time, this would then
imply that individual CMPs differ in the kinetics with which they
contribute to DC versus myeloid/erythroid lineage. Collectively,
these data show a striking heterogeneity within the CMP pool,
greater than previously suggested by in vitro or in vivo experi-
ments that examined output at the population level (Iwasaki
et al., 2005; Nakorn et al., 2003; Nutt et al., 2005; Terszowski
et al., 2005). Importantly, this heterogeneity could not be ex-
plained by detection issues, and it was relatively insensitive to
the threshold used for output classification (Figures S1D–S1I,
S2A, S2B, S3C, and S3D).
To determine at which developmental point the observed diver-
gence between themyeloid and erythroid lineage occurs, we sub-
sequently generated barcode-labeled HSCs (LSK+CD150+) and1658 Cell 163, 1655–1662, December 17, 2015 ª2015 Elsevier Inc.MPPs (LSK+CD150Flt3+, excluding lymphoid-primed multipo-
tent progenitors) (Figure 1B) and, after transplantation, analyzed
their production of myeloid cells and erythroblasts together with
their lymphoid cell production (measured by analysis of CD19+
Bcells) andCD11c+DCcell production (Figure 1D). As previously
described usingcellular barcoding (Gerrits et al., 2010;Naik et al.,
2013), a small number of HSCswere themajor contributors to to-
tal cellular output at day 27 after transplantation, and theseHSCs
were multi-outcome (Figures 3A, 3B, and S4A). With respect to
contribution toward the erythroid and myeloid lineage, >99% of
the total cell output of myeloid cells and erythroblasts was
derived from HSCs (45% ± 7%) that produced both cell types
at this time point (Figures 3C and 3D; quality controls and effect
of classification threshold shown in Figures S5A–S5C). Some
HSCs produced only myeloid cells (10% ± 4%) or erythroblasts
(12% ± 7%), without detectable production of any of the other
cell types (Figure 3B). However, these HSCs collectively contrib-
uted to <0.1%of the total cell output of erythroblasts andmyeloid
cells (Figures 3D and S5C). Furthermore, the occurrence of these
biased HSCs may well be explained by insufficient sensitivity of
detection, as these HSCs have a per progenitor output (as
measured in read counts) toward the erythroid or the myeloid
lineage that is several-fold lower than that of multi-outcome
HSCs for the same lineage (Figure S5D). Also, when assessed
at day 42 after transplantation (Figure S4B), the vast majority of
myeloid cells and erythroblasts (R90%) were derived from
HSCs that contributed to both lineages. In conclusion, the large
majority of erythroid and myeloid cells are produced by multi-
outcome HSCs.
In contrast to this, substantial variability in the ability to
contribute to erythroid and myeloid cell production was
apparent among MPPs (Figures 4A and 4B). At day 14 after
transplantation, only 20% ± 9% of the MPPs produced both
erythroblasts and myeloid cells, irrespective of their capacity
to produce DCs or B cells (Figures 4C and S6; quality controls
and effect of classification threshold shown in Figures S7A
and S7B). While these cells still contributed to a large fraction
of erythroblast output (84% ± 23%), 50% of total myeloid
output was derived from the large pool of MPPs (51% ± 9%)
that produced myeloid cells without producing erythroblasts
(Figures 4D and S7C). Furthermore, contrary to the uni-outcome
biased HSCs, the observation of these myeloid-not-erythroid-
biased MPPs could not be explained by limits of detection, as:
(1) these cells consistently had a per progenitor output (as
measured in read counts in myeloid cells) as high as the per pro-
genitor output (read counts in myeloid cells) of MPP producing
both myeloid cells and erythroblasts (Figure S7D), and (2) their
lack of output in erythroblasts was reproducible in technical rep-
licates before applying the replicate filter (data not shown). Note
that we also detected a significant fraction of MPPs that only
show DC output (Figure 4B), as has also been observed for
lymphoid-primed multipotent progenitors (Naik et al., 2013).
These data show the existence of a subpopulation of true com-
mon progenitors to myeloid and erythroid lineages within the
MPP pool, potentially within the recently described CD41+ cell
population (Miyawaki et al., 2015). However, within the MPP
population, divergence of a myeloid biased subpopulation is
already apparent.
Figure 3. CommonOrigin of Erythrocytes and
Myeloid Cells within HSC, Related to Figures
S4 and S5
Barcode-labeled CD150+ HSCs were transplanted
into 5gy-irradiated mice. At day 27 post-trans-
plantation, myeloid cells (CD11b+), erythroblasts
(Ter119+), B cells (CD19+), and DCs (CD11c+) were
recovered from spleen and barcode content was
analyzed.
(A) Heatmap representation of the output of indi-
vidual CD150+ HSC (rows) to different cell types
(columns), arcsine transformed data.
(B) Proportion of HSCs classified using a 1%
classification threshold in the different possible
categories (averaged over mice).
(C) Same analysis as in (B) but examining erythro-
blast and myeloid cell output only.
(D) Quantitative contribution of the different clas-
ses to myeloid cell and erythroblast production
(mean + SD).
All of the results come from four mice per experi-
ment. Quality controls and other thresholds in
Figure S5.DISCUSSION
The main finding of this work is that the population classically
defined as common myeloid progenitors is highly heteroge-
neous, with most individual CMPs only yielding erythrocytes or
only yielding myeloid cells after transplantation and with some
CMPs contributing toward the DC lineage only. A minor subpop-
ulation is observed that could represent a rare but true subset
of bipotent CMP but may also reflect a contamination of LSK+
cells.
As the existence of a ‘‘common’’ erythro-myeloid progenitor
has been the basis for the model in which the first step of
commitment is formed by the separation between CMP and
CLP, our findings suggest a revised model of hematopoiesis.
Miyawaki et al. (2015) have recently identified a more immature
CMP within the MPP population. Existence of such a common
erythro-myeloid progenitor is still consistent with a model in
which the first step of commitment is formed by the myeloid-
lymphoid split. Likewise, our data also show that a true common
erythro-myeloid progenitor exists within the MPP population.
Importantly though, 40% of the total output of myeloid cells
was derived from progenitors that produced neither erythrocytes
nor lymphoid cells (Figure S7C). These data indicate that, next to
the classical erythro-myeloid versus lymphoid split, an additional
myeloid-only commitment already manifests itself at the MPP
stage.
Alternative models for hematopoiesis have been proposed
in which the megakaryocyte-erythroid lineage branches first,
followed by a myeloid-lymphoid split (Adolfsson et al., 2005; Ari-
nobu et al., 2007). In this model, direct erythropoiesis from HSC
or MPP is predicted to occur independently of myelopoiesis and
lymphopoiesis.We did not observe evidence for a significant roleCell 163, 1655–1662, Dof such an erythroid bypass from either
HSC or MPP. Specifically, of total eryth-
roblast production from HSC or MPP,respectively, only 0.1% ± 0.1% and 9% ± 0.01% was derived
from cells that did not yield myeloid or B cells. Elegant recent
in vivo lineage tracing analysis suggests that transplantation
can skew output of HSCs toward a few dominant clones (Sun
et al., 2014). However, at least under transplantation conditions,
an early erythroid commitment (Yamamoto et al., 2013) is at best
a minor pathway.
The experimental measurements that we make in our work
are the in vivo output of single cells. As such, the strong bias in
single-cell output that we observe could result from the commit-
ment pre-injection of the cells that are used for reconstitution or
from a dominant effect of the niche in which an individual pro-
genitor cell finds itself after transplantation. We strongly believe
that the biased output that we observe for individual progenitor
cells originates from pre-commitment for two reasons. First,
a pre-commitment of, for instance, individual CMP to produce
either erythrocytes or myeloid cells implies an ‘‘encoding’’ of
this commitment at the genetic level, and the observation of sub-
stantial transcriptional heterogeneity between individual cells
within the murine CMP pool by Amit and coworkers (Franziska
et al., 2015 [in this issue of Cell]) provides strong support for
such amodel. Second, if the commitment toward the production
of a single type of output is pre-existing rather than induced by
the niche that is encountered, one would expect to also observe
heterogeneous behavior under in vitro conditions in which indi-
vidual cells all experience identical conditions. In support of
this, Notta et al. (2015) have provided strong evidence that hu-
man bone marrow CMPs and MPPs are highly heterogeneous
and composed of subpopulations with uni-outcome myeloid,
erythroid, andmegakaryocyte potential in in vitro assay systems.
Collectively with these data, our single-cell-tracing data pro-
vide evidence for a model in which multiple combinations ofecember 17, 2015 ª2015 Elsevier Inc. 1659
Figure 4. Divergence between Erythrocyte
and Myeloid Output within the MPP Pool,
Related to Figures S6 and S7
Barcode-labeled MPPs were transplanted into
5gy-irradiated mice. At day 14 post-transplantation,
myeloid cells (CD11b+), erythroblasts (Ter119+),
B cells (CD19+), and DCs (CD11c+) were recovered
from spleen and barcode content was analyzed.
(A) Heatmap representation of the output of indi-
vidual MPPs (rows) to different cell types (columns),
arcsine transformed data.
(B) Proportion of MPPs classified using a 1% clas-
sification threshold in the different possible cate-
gories (average over mice).
(C) Same analysis as (B) but examining erythroblasts
and myeloid cell output only.
(D) Quantitative contribution of the classes to
myeloid cell and erythroblast production from bar-
code-labeled MPPs (mean + SD).
All results come from four mice per experiment.
Quality controls and other thresholds in Figure S7.lineage commitments (e.g., erythroid-myeloid, myelo-lymphoid)
are already manifest during the transition of the MPP stage
of hematopoietic development. The combination of single-cell
transcriptomics and single-cell-lineage tracing, preferably under
conditions of unperturbed hematopoiesis (Sun et al., 2014;
Busch et al., 2015) should help reveal how sibling cells commit
to different types of output at this stage.
EXPERIMENTAL PROCEDURES
Mice, Progenitor Isolation, and Barcode Labeling
C57BL/6J (CD45.2) donor mice and C57BL/6 Pep3b (CD45.1) recipient mice
irradiated with 5 gy were used in all experiments. Labeling of cells with the len-
tiviral barcode library was performed as described in Naik et al. (2013). In brief,
bone marrow was harvested from femurs, tibias, and ilia and enriched using
anti-CD117 magnetic beads (Miltenyi). The c-kit+ fraction was stained with an-
tibodies against CD16/32 (FITC, clone 24G2, BD PharMingen or PerCPCy5.5,
clone 24G2, BDBiosciences), CD117 (c-kit APC, clone 2B8, Biolegend), Sca-1
(Pacific Blue, clone D7, Biolegend), CD135 (Flt3 PE, clone A2F10, ebioscien-
ces), CD34 (alexa700, clone RAM34, ebioscience), and CD150 (Slam PEcy7,
clone TC15-12F12.2, Biolegend). MPPs, CMPs, and HSCs were sorted using
a strategy similar to that described previously (Akashi et al., 2000) (Figures 1B
and 1C). For the experiment, up to 105 progenitors were transduced for 6 hr in
stem cell medium (stempan SFEM, Stem Cell Technologies) with 50 ng/ml
stem cell factor (SCF). For the first 90 min of transduction, progenitors were
centrifuged at 200 rpm (low brake) and cells were subsequently incubated at
37C for 4.5 hr. Following transduction, cells were washed, resuspended in
saline solution, and injected intravenously into at least two recipient mice.
Efficiency of transduction ranged between 10%–40%.
Cell Isolation
Cell suspensions were derived from spleen or bone marrow of killed mice and
positively selected for Ter119 expression using biotinylated anti-Ter119 anti-
body (BD PharMingen) and anti-biotin beads (Miltenyi). The Ter119 fraction
was stained at 4C using a combination of antibodies against CD45.2 (Pacific
blue, clone 104, Biolegend), CD11C (APC, clone HC3, BD biosciences),1660 Cell 163, 1655–1662, December 17, 2015 ª2015 Elsevier Inc.CD11b (PercPCy5.5, clone M1/70, ebioscience),
CD19 (APC-Cy7, clone 1D3, BD PharMingen), and
Ter119 (PEcy7, BD PharMingen) to sort myeloid
cells, B cells, and DCs (Figure 1D). The Ter119+ frac-
tion was stained at 4Cwith antibody against Ter119
(Pecy7, BD PharMingen) to sort the erythroblast fraction (Figure 1D). Output
cell types were sorted following the gating strategy in Figure 1D, and cell
numbers are depicted in Table S1.
PCR and Sequencing
Sorted cell samples were lysed in Viagen buffer (direct PCR, Viagen) and split
into technical replicates (Schumacher et al., 2010). Barcodes were amplified
by nested PCR as previously described in Naik et al. (2013). In brief, barcode
sequences were first amplified using top-LIB (50TGCTGCCGTCAACTAG
AACA-30) and bot-LIB (50GATCTCGAATCAGGCGCTTA-30 ) primers (30 cycles:
15 s at 95C; 15 s at 57.2C; 15 s at 72C). PCR products were then subjected
to a second PCR (30 cycles: 5 s at 94C; 5 s at 57.2C; 5 s at 72C) in which
the P5 and P7 (50-CAAGCAGAAGACGGCATACGAGAT-30) adaptors required
for sequencing on Illumina platforms as well as a unique 8 bp index and a
sequencing primer annealing site were attached. Primers used were as
follows: forward (50-P5-seq_prim-index-CAGGCGCTTAGGATCC-30 ) and
reverse (50-P7-TGCTGCCGTCAACTAGAACA-30). Up to 192 tagged PCR
products were pooled and sequenced by next-generation sequencing using
a HiSeq2000 or HiSeq2500 platform (Illumina). Total read lengths were
50–60 bp, of which the first 22 bp consisted of the index and constant regions.
The following 15 bp were used to distinguish between different barcodes.
Filtering Procedure
Sequence reads were first screened for quality by the software packages that
are part of the Illumina pipeline, and only high-quality reads were selected
(10–70 3 106 per run). Subsequently, only reads showing a 100% match
to the expected scheme (index-CAGGCGCTTAGGATCC-random_sequence)
were selected (typically >90% of reads), whereby a 100% match to one of
the 192 index sequences was required. Of the random sequence (the bar-
code), only the first 15 bp were considered. To filter out reads that reflect
PCR or sequencing errors within the 15 bp barcode region, all filtered reads
were compared to a barcode reference list (Gerlach et al., 2013), and only
sequences that showed a 100% match to one of the sequences within the
barcode reference file were maintained (typically 80%–93%).
Using a customized script in R (R Development Core Team, 2014), we
subsequently applied a filtering procedure composed of three steps, similar
to the procedure used in Naik et al. (2013). Specifically, samples for which
insufficient read counts were obtained during deep sequencing (average of
the two technical replicates <103, compared to the expected 105) were first
excluded. Samples having passed this step were then normalized to 105 reads
for each sample. To control the quality of the analysis of the barcode content of
a given sample, we additionally excluded samples in which the two technical
replicates displayed a Pearson correlation coefficient of <0.8. These technical
replicate controls are essential to give confidence in whether barcode expan-
sion and cell type recovery were sufficient for informative lineage relationship
analysis. Third, after passing these technical replicate quality controls, all
reads of barcodes present in only one of the two technical replicates of a given
sample—an indication that there was a low confidence for inclusion of that
barcode—were changed to zero (0) reads for that sample. Resulting data
were collated in a table of normalized barcode read counts in each cell type.
Barcode Analysis and Barcode Classification
For heatmap analysis, read counts were transformed using the hyperbolic
arcsine function that is similar to a logarithmic function but can accommodate
barcode reads with a value of 0. After confirming that technical replicates
yielded similar data, as described above and by visual inspection (Figures
S1A, S5A, and S7A), their average was taken for further analysis.
To classify individual progenitors by their lineage bias, we used a previously
published hand-tailored classifier (Naik et al., 2013). In summary, an additional
normalization per progenitor was applied in each mouse, thereby enabling
categorization into classes of biased output toward the analyzed lineages
(myeloid cells, erythroblasts, DCs, or B cells, depending on the experiment).
Potency to contribute to a given lineage was assigned if >1% of the output
of a given CMP, MPP, or HSC was toward that lineage (Figures 2–4). Other
thresholds were also analyzed (Figures S2, S3, S5, and S7).
Quality Controls
To illustrate the quality of the samples, the barcodes found in both duplicates
of the same sample are always compared and representative plots of each
experiment are provided in the supplemental figures (Figures S2, S3, S5,
S7). Furthermore, by cross-comparing two mice that received barcoded
progenitors from the same transduction batch, the extent of ‘‘repeat use’’—in-
stances in which two progenitors are transduced with virus particles that har-
bor the same barcode—was always compared and was found to be minimal
(Figures S2, S3, S5, S7).
Uni-outcome progenitors were further analyzed for potential detection
issues by: (1) determining whether the distribution of clonal outputs of uni-
outcome progenitors toward one specific lineage was similar to the clonal
output toward the same lineage of multi-outcome progenitors, and (2) deter-
mining whether the lack of output of uni-outcome progenitors toward the other
lineages was reproducible in technical replicates before applying the replicate
filter.
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